LY3053102

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LY3053102, covering 2017-12-20 to 2018-07-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3053102 in Healthy Participants [Phase 1]